STAT+: Latigo reports mid-stage success for would-be rival to Vertex’s pain drug Journavx
STAT News · LC · trust 37/100
Latigo Biotherapeutics published positive data for an acute-pain drug meant to rival a Vertex medicine already on the market
Read the original at STAT News →
Open in TruthVane →